X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide
2. 2-(2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide
3. Abt 888
4. Abt-888
5. Abt888
1. 912444-00-9
2. Abt-888
3. Abt 888
4. Abt-888 (veliparib)
5. Veliparib Free Base
6. Abt888
7. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benzo[d]imidazole-4-carboxamide
8. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide
9. 2-[(2r)-2-methyl-2-pyrrolidinyl]-1h-benzimidazole-7-carboxamide
10. Chebi:62880
11. 2-[(r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide
12. Parp-1 Inhibitor Abt-888
13. 912444-00-9 (free Base)
14. 01o4k0631n
15. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benimidazole-4-
16. (2r)-2-(7-carbamoyl-1h-benzimidazol-2-yl)-2-methylpyrrolidinium
17. 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide
18. Veliparib (abt-888)
19. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benimidazole-4-carboxamide (veliparib)
20. 2-((2r)-2-methyl-2-pyrrolidinyl)-1h-benzimidazole-7-carboxamide
21. 2-((2r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide
22. Nsc-737664
23. Veliparib [usan:inn]
24. Mfcd16661059
25. Unii-01o4k0631n
26. 78p
27. Veliparib [inn]
28. Veliparib [jan]
29. Veliparib [usan]
30. Abt888 (free Base)
31. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benzo[d]imidazole-7-carboxamide
32. Veliparib [who-dd]
33. Benzimidazole Carboxamide, 3a
34. Mls006010184
35. Veliparib (jan/usan/inn)
36. Schembl422318
37. Chembl506871
38. Gtpl7417
39. Bdbm27135
40. Abt-695
41. Dtxsid90238456
42. Ex-a001
43. Bdbm209932
44. Veliparib (abt-888 Hydrochloride)
45. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-1,3-benzodiazole-4-carboxamide
46. Nsc737664
47. Nsc752840
48. S1004
49. Zinc84610155
50. Akos015951440
51. Akos017343746
52. Ccg-264771
53. Cs-0076
54. Db07232
55. Ex-7209
56. Nsc 737664
57. Nsc-752840
58. Sb16480
59. Ncgc00250404-01
60. Ncgc00250404-15
61. Ac-23330
62. As-19397
63. Hy-10129
64. Smr004701290
65. Abt-888 (veliparib, Nsc 737664)
66. A24888
67. D09692
68. A 861695
69. A-861695
70. J-505211
71. Q7919041
72. Brd-k87142802-001-02-7
73. 1h-benzimidazole-4-carboxamide, 2-((2r)-2-methyl-2-pyrrolidinyl)-
74. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benimidazole-4-carboxamide
75. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-7-carboxamide
76. 2-[(r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide;
77. 1h-benzimidazole-7-carboxamide, 2-((2r)-2-methyl-2-pyrrolidinyl)-
| Molecular Weight | 244.29 g/mol |
|---|---|
| Molecular Formula | C13H16N4O |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 244.13241115 g/mol |
| Monoisotopic Mass | 244.13241115 g/mol |
| Topological Polar Surface Area | 83.8 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 348 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of fallopian tube cancer , Treatment of ovarian cancer , Treatment of peritoneal carcinoma
Treatment of lung carcinoma (small cell and non-small cell carcinoma)
Treatment of breast cancer
Treatment of high-grade glioma
Poly(ADP-ribose) Polymerase Inhibitors
Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XK - Poly (adp-ribose) polymerase (parp) inhibitors
L01XK05 - Veliparib
Market Place
